257 related articles for article (PubMed ID: 8987838)
1. GDNF selectively protects dopamine neurons over serotonin neurons against the neurotoxic effects of methamphetamine.
Cass WA
J Neurosci; 1996 Dec; 16(24):8132-9. PubMed ID: 8987838
[TBL] [Abstract][Full Text] [Related]
2. Augmented methamphetamine-induced overflow of striatal dopamine 1 day after GDNF administration.
Cass WA; Walker DJ; Manning MW
Brain Res; 1999 May; 827(1-2):104-12. PubMed ID: 10320698
[TBL] [Abstract][Full Text] [Related]
3. GDNF protection against 6-OHDA-induced reductions in potassium-evoked overflow of striatal dopamine.
Cass WA; Manning MW
J Neurosci; 1999 Feb; 19(4):1416-23. PubMed ID: 9952418
[TBL] [Abstract][Full Text] [Related]
4. Restorative effects of GDNF on striatal dopamine release in rats treated with neurotoxic doses of methamphetamine.
Cass WA; Manning MW; Bailey SL
Ann N Y Acad Sci; 2000 Sep; 914():127-36. PubMed ID: 11085315
[TBL] [Abstract][Full Text] [Related]
5. Protection by GDNF and other trophic factors against the dopamine-depleting effects of neurotoxic doses of methamphetamine.
Cass WA; Peters LE; Harned ME; Seroogy KB
Ann N Y Acad Sci; 2006 Aug; 1074():272-81. PubMed ID: 17105923
[TBL] [Abstract][Full Text] [Related]
6. Recovery of presynaptic dopaminergic functioning in rats treated with neurotoxic doses of methamphetamine.
Cass WA; Manning MW
J Neurosci; 1999 Sep; 19(17):7653-60. PubMed ID: 10460271
[TBL] [Abstract][Full Text] [Related]
7. Calcitriol protects against the dopamine- and serotonin-depleting effects of neurotoxic doses of methamphetamine.
Cass WA; Smith MP; Peters LE
Ann N Y Acad Sci; 2006 Aug; 1074():261-71. PubMed ID: 17105922
[TBL] [Abstract][Full Text] [Related]
8. Intranigral ventral mesencephalic grafts and nigrostriatal injections of glial cell line-derived neurotrophic factor restore dopamine release in the striatum of 6-hydroxydopamine-lesioned rats.
Tang FI; Tien LT; Zhou FC; Hoffer BJ; Wang Y
Exp Brain Res; 1998 Apr; 119(3):287-96. PubMed ID: 9551829
[TBL] [Abstract][Full Text] [Related]
9. Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor.
Choi-Lundberg DL; Lin Q; Schallert T; Crippens D; Davidson BL; Chang YN; Chiang YL; Qian J; Bardwaj L; Bohn MC
Exp Neurol; 1998 Dec; 154(2):261-75. PubMed ID: 9878166
[TBL] [Abstract][Full Text] [Related]
10. Decreases in evoked overflow of dopamine in rat striatum after neurotoxic doses of methamphetamine.
Cass WA
J Pharmacol Exp Ther; 1997 Jan; 280(1):105-13. PubMed ID: 8996187
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 protein Tat potentiation of methamphetamine-induced decreases in evoked overflow of dopamine in the striatum of the rat.
Cass WA; Harned ME; Peters LE; Nath A; Maragos WF
Brain Res; 2003 Sep; 984(1-2):133-42. PubMed ID: 12932847
[TBL] [Abstract][Full Text] [Related]
12. Neurturin protects against 6-hydroxydopamine-induced reductions in evoked dopamine overflow in rat striatum.
Cass WA; Peters LE
Neurochem Int; 2010 Nov; 57(5):540-6. PubMed ID: 20615442
[TBL] [Abstract][Full Text] [Related]
13. Enhanced glial cell line-derived neurotrophic factor mRNA expression upon (-)-deprenyl and melatonin treatments.
Tang YP; Ma YL; Chao CC; Chen KY; Lee EH
J Neurosci Res; 1998 Sep; 53(5):593-604. PubMed ID: 9726430
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of glial cell line-derived neurotrophic factor (GDNF) in the striatum and substantia nigra of the aged Parkinsonian rat.
Connor B; Kozlowski DA; Schallert T; Tillerson JL; Davidson BL; Bohn MC
Gene Ther; 1999 Dec; 6(12):1936-51. PubMed ID: 10637445
[TBL] [Abstract][Full Text] [Related]
15. Behavioral and neurochemical effects of intranigral administration of glial cell line-derived neurotrophic factor on aged Fischer 344 rats.
Hebert MA; Gerhardt GA
J Pharmacol Exp Ther; 1997 Aug; 282(2):760-8. PubMed ID: 9262339
[TBL] [Abstract][Full Text] [Related]
16. Effects of 2-deoxy-D-glucose on methamphetamine-induced dopamine and serotonin neurotoxicity.
Callahan B; Yuan J; Stover G; Hatzidimitriou G; Ricaurte G
J Neurochem; 1998 Jan; 70(1):190-7. PubMed ID: 9422362
[TBL] [Abstract][Full Text] [Related]
17. Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle.
Rosenblad C; Kirik D; Devaux B; Moffat B; Phillips HS; Björklund A
Eur J Neurosci; 1999 May; 11(5):1554-66. PubMed ID: 10215908
[TBL] [Abstract][Full Text] [Related]
18. Long-term methamphetamine-induced decreases of [(11)C]WIN 35,428 binding in striatum are reduced by GDNF: PET studies in the vervet monkey.
Melega WP; Lacan G; Desalles AA; Phelps ME
Synapse; 2000 Mar; 35(4):243-9. PubMed ID: 10657033
[TBL] [Abstract][Full Text] [Related]
19. The effect of intrastriatal single injection of GDNF on the nigrostriatal dopaminergic system in hemiparkinsonian rats: behavioral and histological studies using two different dosages.
Aoi M; Date I; Tomita S; Ohmoto T
Neurosci Res; 2000 Apr; 36(4):319-25. PubMed ID: 10771110
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effects of GDNF against 6-OHDA in young and aged rats.
Fox CM; Gash DM; Smoot MK; Cass WA
Brain Res; 2001 Mar; 896(1-2):56-63. PubMed ID: 11277973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
